keyword
https://read.qxmd.com/read/38584856/treatment-modalities-for-paediatric-functional-daytime-lower-urinary-tract-disorders-an-updated-review
#21
REVIEW
Naveen Wijekoon, Aniruddh Deshpande
Paediatric functional bladder disorders especially those causing daytime symptoms are a common cause of significant psychosocial and/or physical morbidity and impaired quality of life. Despite the availability of many therapeutic modalities, a significant number of children appear to be refractory to treatment and continue to have symptoms. In this review, we aim to evaluate the current evidence in the use of existing and novel therapeutic options for the management of daytime lower urinary tract disorders in children...
2024: Therapeutic Advances in Urology
https://read.qxmd.com/read/38583390/successful-treatment-of-cranial-dystonia-using-a-zolpidem-melatonin-combination-a-video-case-series
#22
JOURNAL ARTICLE
Narendrakumar H Barad, Eoin Mulroy
INTRODUCTION: Cranial dystonias (CrD) are challenging to treat. Oral pharmacotherapy is often sub-optimal, while delicate anatomy and limited availability of skilled botulinum toxin injectors makes this approach risky, and often difficult to access; neurosurgical options e.g. deep brain stimulation, are high-risk in the elderly populations most affected. We observed significant improvement in CrD in 2 patients prescribed Zolpidem+Melatonin combination treatment for insomnia, and therefore trialled this treatment in a further 4 patients with CrD...
April 3, 2024: Journal of the Neurological Sciences
https://read.qxmd.com/read/38581447/is-bulbospongiosus-muscle-botox-injection-safe-and-effective-in-treating-lifelong-premature-ejaculation-randomized-controlled-study
#23
JOURNAL ARTICLE
Hussein Shaher, Karem Noah, Mohamed Abdelzaher, Wael Kandil, Islam Saied Ahmed, Islam S Nouh
PURPOSE: To evaluate the safety and efficacy of botulinum-A toxin injections into the bulbospongiosus muscle for cases of lifelong drug-resistant premature ejaculation (PE). METHODS: Ninety-eight outpatients diagnosed with lifelong PE were randomly assigned to two groups: the botulinum-A toxin group comprising forty-nine patients and the placebo (saline) group also consisting of forty-nine patients. A 100 U botulinum-A toxin was diluted into 10 cc of saline, with 5 cc injected into one side of the muscle (botulinum-A toxin group) guided by ultrasound to distribute across most muscle fibers...
April 6, 2024: World Journal of Urology
https://read.qxmd.com/read/38576368/retrograde-cricopharyngeus-dysfunction-a-new-motility-disorder-single-center-case-series-and-treatment-results
#24
JOURNAL ARTICLE
Stijn Arnaert, Joris Arts, Karlien Raymenants, Filip Baert, Kathelijne Delsupehe
BACKGROUND/AIMS: Retrograde cricopharyngeus dysfunction (R-CPD) is a new clinical entity characterized by inability to belch and associated symptoms of loud gurgling noises, chest and/or abdominal pressure, abdominal bloating, and excessive flatulence. R-CPD can be treated with botulinum toxin (BT) injection in the upper esophageal sphincter. We hereby report patient demographics, symptomatology, and treatment results of a series of consecutive patients who presented at our center. METHODS: Data on 50 consecutive patients presenting with R-CPD were prospectively collected using a standardized questionnaire prior to, 1 month after treatment and at the end of follow-up...
April 30, 2024: Journal of Neurogastroenterology and Motility
https://read.qxmd.com/read/38576226/aesthetic-doctors-perception-and-attitudes-toward-tolerance-in-botulinum-toxin
#25
JOURNAL ARTICLE
Seung Min Oh, Hyoung Moon Kim, Tae Hwan Ahn, Min Soo Park, Yoo-Seock Ree, Eun Soo Park
BACKGROUND: Botulinum toxin is a crucial therapeutic tool with broad indications in both cosmetic and medical fields. However, the expanding cosmetic use and increased dosages of botulinum toxin have raised concerns about resistance, making it essential to study the awareness and management practices among healthcare professionals. METHODS: A survey was conducted among clinical physicians using botulinum toxin. The study investigated their experiences, awareness, and management practices related to toxin resistance...
April 2024: Skin Research and Technology
https://read.qxmd.com/read/38575452/botulinum-toxin-a-as-a-treatment-option-for-refractory-idiopathic-trigeminal-neuralgia-of-the-ophthalmic-branch-a-case-report-and-literature-review
#26
REVIEW
Ahammad Kandari, Beena A T Pravin Devaprasad, Patricia Hernandez-Rivera, Ivonne A Hernandez, Reid Friesen
Trigeminal neuralgia is one of the most common neurological pains affecting the head and neck and is associated with severe, lancinating, electrical pain episodes. The maxillary and mandibular branches are usually affected. The ophthalmic branch is rarely involved and, when present, it requires a comprehensive workup to rule out major conditions. Pharmacotherapy and surgery are the most common treatment options for this condition. Systemic medications may pose a wide range of side effects and effectiveness may decrease over time while surgery has inherent complications...
March 2, 2024: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
https://read.qxmd.com/read/38572653/treating-neuropathic-pain-and-comorbid-affective-disorders-preclinical-and-clinical-evidence
#27
REVIEW
David Richer Araujo Coelho, Maia Gersten, Alma Sanchez Jimenez, Felipe Fregni, Paolo Cassano, Willians Fernando Vieira
INTRODUCTION: Neuropathic pain (NP) significantly impacts quality of life and often coexists with affective disorders such as anxiety and depression. Addressing both NP and its psychiatric manifestations requires a comprehensive understanding of therapeutic options. This study aimed to review the main pharmacological and non-pharmacological treatments for NP and comorbid affective disorders to describe their mechanisms of action and how they are commonly used in clinical practice. METHODS: A review was conducted across five electronic databases, focusing on pharmacological and non-pharmacological treatments for NP and its associated affective disorders...
April 4, 2024: Pain Practice: the Official Journal of World Institute of Pain
https://read.qxmd.com/read/38572390/botulinum-toxin-and-progressive-pneumoperitoneum-in-loss-of-domain-ventral-hernias-a-systematic-review
#28
REVIEW
Mario Giuffrida, Federico Biolchini, Patrizio Capelli, Filippo Banchini, Gennaro Perrone
Introduction: Preoperative progressive pneumoperitoneum (PPP) and botulinum toxin A (BTX) have been used together in the preoperative preparation of patients with loss of domain hernias. This study aims to evaluate the efficacy and safety of the combined use of PPP and BTX. Methods: A systematic electronic search was performed according to the PRISMA criteria. A literature search of scientific articles was conducted up to December 2023. Articles were chosen based on the reference to BTX and PPP in loss of domain ventral hernias with a defect width greater than 10 cm before surgery...
2024: J Abdom Wall Surg
https://read.qxmd.com/read/38572295/a-case-report-of-herpes-zoster-after-botulinum-toxin-injections
#29
Shadi Zari
This case report presents a rare occurrence of herpes zoster (HZ) outbreak in a 50-year-old male following botulinum toxin (BTX) type A injections. The patient developed burning swollen lesions on the left forehead four days after receiving BTX injections. Physical examination revealed papules and erosions in a dermatomal distribution. He was diagnosed with HZ and promptly treated with oral acyclovir. The lesions resolved within two weeks without complications. Previous literature reports a few similar HZ outbreaks following aesthetic treatments with BTX injections...
2024: International Medical Case Reports Journal
https://read.qxmd.com/read/38569620/efficacy-and-safety-of-low-dose-intravesical-onabotulinumtoxina-injections-in-female-patients-with-detrusor-overactivity-with-detrusor-underactivity
#30
JOURNAL ARTICLE
Hyun Seok Na, Chung Lyul Lee, Jae Sung Lim, Ki Hak Song, Ju Hyun Shin, Jong Mok Park, Ji Yong Lee
PURPOSE: We assessed the effectiveness and safety of using intravesical onabotulinumtoxinA (onabotA; BOTOX) injection with a low dose (75 units) for treating urinary storage symptoms in patients with detrusor overactivity with detrusor underactivity (DODU) compared to using the standard 100 units of onabotA in patients with overactive bladder (OAB). METHODS: This ambidirectional study included 121 female patients who received intravesical onabotA injections at our hospitals...
March 2024: International Neurourology Journal
https://read.qxmd.com/read/38569195/a-brief-review-of-complex-regional-pain-syndrome-and-current-management
#31
REVIEW
Alaa Abd-Elsayed, Cain W Stark, Natasha Topoluk, Mir Isaamullah, Paul Uzodinma, Omar Viswanath, Michael J Gyorfi, Osama Fattouh, Kevin C Schlidt, Omar Dyara
Complex regional pain syndrome (CRPS) is a debilitating chronic pain condition that, although exceedingly rare, carries a significant burden for the affected patient population. The complex and ambiguous pathophysiology of this condition further complicates clinical management and therapeutic interventions. Furthermore, being a diagnosis of exclusion requires a diligent workup to ensure an accurate diagnosis and subsequent targeted management. The development of the Budapest diagnostic criteria helped to consolidate existing definitions of CRPS but extensive work remains in identifying the underlying pathways...
December 2024: Annals of Medicine
https://read.qxmd.com/read/38566853/hemimasticatory-spasm-a-series-of-17-cases-and-a-comprehensive-review-of-the-literature
#32
JOURNAL ARTICLE
Kazuya Yoshida
Hemimasticatory spasm (HMS) is a rare movement disorder characterized by paroxysmal spasms or twitches of the unilateral jaw-closing muscles. This study aimed to comprehensively evaluate the clinical features of patients with HMS. Data from 17 patients newly diagnosed with HMS (12 females and 5 males; mean age at onset: 46.7 years) who visited our department were retrospectively analyzed, and a literature search based on electronic medical databases from their inception until November 30, 2023, was conducted...
2024: Frontiers in Neurology
https://read.qxmd.com/read/38566435/the-gold-protocol-a-combined-treatment-approach-for-neck-rejuvenation-with-calcium-hydroxyapatite-botulinum-toxin-and-hyaluronic-acid-in-the-same-session
#33
JOURNAL ARTICLE
Carla de Sanctis Pecora
BACKGROUND: The signs of aging seem to be more visible on the neck compared to other locations, especially if a patient has already gone through facial rejuvenation procedures. Treatment of the aging neck imposes a challenge to the clinician, since one single approach is usually not enough to achieve the desired result, requiring multiple injections and sessions, which apart from being painful for the patients, is time-consuming for the clinician. AIM: To describe the use of calcium hydroxyapatite, incobotulinum toxin type A and Cohesive poly-densified matrix hyaluronic acid diluted in the same syringe and injected in the same session for neck rejuvenation...
April 2, 2024: Journal of Cosmetic Dermatology
https://read.qxmd.com/read/38564274/-achalasia-cardiae-causing-megaesophagus-from-the-beginnings-to%C3%A2-the-resolution
#34
JOURNAL ARTICLE
Barbara Galiger, Ferenc Ender, Ágnes Bohák, Géza Telek, Attila Vörös
Achalasia cardiae miatt az első oesophago-cardia myotomiát több mint száz évvel ezelőtt Ernst Heller német sebész végezte. Az achalasiás betegek a mai napig ettől a beavatkozástól várják panaszaik megszűnését. Az achalasia napjainkban is chronikus, progresszív betegség, aminek oki kezelését nem ismerjük, a gyógyítására, a panaszok enyhítésére gyógyszeres (calcium csatorna blokkolók stb...
April 2, 2024: Magyar Sebészet
https://read.qxmd.com/read/38564007/retrograde-cricopharyngeal-dysfunction-and-treatment-with-botulinum-toxin-a-systematic-review
#35
REVIEW
Clara Helena Jönsson, Christina Caroline Plaschke
PURPOSE: Retrograde cricopharyngeal dysfunction (RCPD) is a disease first described systematically in 2019. The main symptom is inability to belch due to cricopharyngeal muscle dysfunction. Other symptoms include gurgling noises, chest pain, bloating, and excessive flatulence. This paper aims to describe RCPD, the aetiology and diagnosis, treatment options, follow-up, and treatment with botulinum toxin (BT). METHODS: A systematic review was done according to the PRISMA guidelines, using the databases PubMed, Embase, and Cochrane at 8/3/2024...
April 2, 2024: European Archives of Oto-rhino-laryngology
https://read.qxmd.com/read/38562271/weekly-acupuncture-for-a-patient-with-hemifacial-spasms-a-case-report
#36
Go Horibe, Satoru Yamaguchi, Ai Kouchi, Shintaro Ibata, Toshimasa Yamamoto
The efficacy and optimal frequency of acupuncture for hemifacial spasms (HFSs) in patients unresponsive or averse to standard treatment methods remains unestablished. Here, we administered acupuncture to a patient with HFSs who was dissatisfied with the outcomes of botulinum toxin (BoNT) injections as symptomatic treatment. A man in his 60s, experiencing frequent spasms in his left facial muscles since 2015, had received several BoNT injections without receiving microvascular decompression or medication; however, the treatment results were not satisfactory...
February 2024: Curēus
https://read.qxmd.com/read/38561027/inhibition-of-listeria-monocytogenes-and-clostridium-botulinum-in-uncured-shredded-pork-and-turkey-packaged-under-reduced-oxygen-conditions
#37
JOURNAL ARTICLE
Kathleen A Glass, Max Golden, Brandon Wanless, Tina Conklin, Jeannine P Schweihofer, Kristin Schill
Cooked, uncured meat products packaged under reduced oxygen packaging conditions require the control of anaerobic and facultative anaerobic pathogens if they are held at temperatures greater than 3°C at retail or consumer level. The objective of this study was to determine the inhibition of Listeria monocytogenes and Clostridium botulinum in cooked, uncured shredded turkey and pork formulated with synthetic or clean label antimicrobials. Treatments of shredded meat products were prepared with or without antimicrobials using turkey thigh or breast that were cooked to 85°C, shredded, and chilled before inoculation with the target pathogen...
March 30, 2024: Journal of Food Protection
https://read.qxmd.com/read/38560731/efficacy-of-botulinum-toxin-a-combined-with-extracorporeal-shockwave-therapy-in-post-stroke-spasticity-a-systematic-review
#38
Ya-Nan Du, Yang Li, Ting-Yu Zhang, Nan Jiang, Ying Wei, Shi-Huan Cheng, He Li, Hao-Yang Duan
OBJECTIVES: In recent years, there has been an increase in the number of randomized clinical trials of BTX-A combined with ESWT for the treatment of post-stroke spasticity. This has made it possible to observe the benefits of combination therapy in clinical practice. Therefore, this paper reviews the effectiveness of BTX-A in combination with ESWT for the treatment of post-stroke spasticity. METHODS: By October 2023, a systematic review was conducted in the databases PubMed, Cochrane, Embase, Medline, Web of Science, China National Knowledge Infrastructure, Wan Fang Database, China Biology Medicine disc and China Science and Technology Journal Database were systematically searched...
2024: Frontiers in Neurology
https://read.qxmd.com/read/38558551/botox-in-below-knee-amputation-for-the-management-of-post-operative-contracture-a-systematic-review
#39
REVIEW
Ahmmad Alfatih, Basil Ibrahim, Abduelraheim Abu, Maysa Hamza, Iman Hassan
During the 1970s, scientists first used botulinum toxin to treat strabismus. While testing on monkeys, they noticed that the toxin could also reduce wrinkles in the glabella area. This led to its widespread use in both medical and cosmetic fields. The objective of the study was to evaluate the potential use of Botox in managing post-operative contracture after below-knee amputation. We conducted a systematic review In Pubmed, Cochrane Library, Embase, and Google Scholar using the MESH terms Botox, botulinum toxin, post-operative contracture, amputation, and below knee amputation...
2024: Pan African Medical Journal
https://read.qxmd.com/read/38558383/compared-to-oxcarbazepine-and-carbamazepine-botulinum-toxin-type-a-is-a-useful-therapeutic-option-for-trigeminal-neuralgia-symptoms-a-systematic-review
#40
REVIEW
Yeganeh Naderi, Maryam Rad, Ali Sadatmoosavi, Elham Khaleghi, Zahra Khorrami, Goli Chamani, Mohammad Shabani
OBJECTIVES: This review aimed to compare the effectiveness of three treatments: BTX A, CBZ, and OXB, in managing trigeminal neuralgia (TN). MATERIAL AND METHODS: We conducted a thorough search for research articles related to our issue using specific keywords on several databases, including Cochrane Central Register of Controlled Trials, Science Direct, Scopus, PubMed, Elsevier, Springer Journals, Ovid Medline, EBSCO, and Web of Science. Our focus was on publications from 1965 to 2023...
April 2024: Clinical and Experimental Dental Research
keyword
keyword
5046
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.